Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
January 31, 2008

Laureate Inks Manufacturing Contract to Help Arius Advance Cancer Program

  • Laureate Pharma entered into a cGMP manufacturing agreement with Arius Research for its Trop-2 signal transduction antibody program.

    Laureate will produce Arius’ IgG1 humanized antibody under the agreement. The product targets a novel marker that has been linked to aggressive cancers including pancreatic, colon, breast, and prostate cancer, according to Arius.

  • You’re all set! Thank you for subscribing to GEN Highlights.